Records containing: Hepatitis C Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-03-14A Clinical Safety Study of the Aethlon Hemopurifier® in Chronic ESRD Patients With HCV Infection
-
CLINICAL_TRIALS study record update · 2017-01-11An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
-
CLINICAL_TRIALS study record update · 2016-08-04Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study
-
CLINICAL_TRIALS study record update · 2016-04-26A Phase I Study to Assess the Safety and Immunogenicity of AdCh3NSmut and MVA-NSmut in Healthy Volunteers and Patients With Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2016-03-04A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects Who Have Failed Prior Treatment With Pegylated Interferon and Ribavirin (P/R) With Chronic HCV GT1, GT4, and GT6 Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-01-18Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2015-10-23A Phase 2a Study of BMS-790052 in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype 1
-
CLINICAL_TRIALS study record update · 2015-10-12A Phase 2a Study of BMS-790052 in Combination With Peginterferon Alfa-2b (PegIntron®) and Ribavirin (Rebetol®) in Japanese Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
-
CLINICAL_TRIALS study record update · 2015-10-09A Phase 2a Study of BMS-790052 and BMS-650032 in Combination Therapy With Japanese Subjects With Genotype 1 Chronic Hepatitis C (HCV) Virus Infection
-
CLINICAL_TRIALS study record update · 2015-09-23Prospective, Single-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy With Pegylated Interferon, Ribavirin, and Boceprevir in Patients With Genotype 1 Chronic HCV With End Stage Renal Disease
-
CLINICAL_TRIALS study record update · 2015-09-11A Phase 2a Study of Daclatasvir in Combination With Peginterferon Alfa-2a(Pegasys®) and Ribavirin (Copegus®) in Japanese Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
-
CLINICAL_TRIALS study record update · 2015-06-30Response Guided Therapy (RGT) for Boceprevir Combined With Peginterferon Alpha-2b Plus Ribavirin in Naïve Hispanic Patients With Genotype 1 Hepatitis C Infection
-
CLINICAL_TRIALS study record update · 2015-02-24A Bioequivalence Study of the 90-mg Daclatasvir Tablet Relative to the 3 × 30-mg Daclatasvir Phase 3 Tablets, and Relative Bioavailability Studies of Chewable Pediatric Tablets of Daclatasvir and Asunaprevir in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2015-02-10Effect of a Combination of Daclatasvir, Asunaprevir, and BMS-791325 on the Pharmacokinetics of Selective Serotonin Reuptake Inhibitors in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2013-05-15An Open-Label Safety and Tolerability Study of Nitazoxanide, Pegylated-Interferon Alfa 2a and Ribavirin in HIV/HCV Co-Infected Genotype 1 Prior Treatment Relapsers and Non-Responders
-
CLINICAL_TRIALS study record update · 2012-12-21Effects of Vitamin D on Inflammation in Liver Disease
-
CLINICAL_TRIALS study record update · 2012-12-12A Pilot Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
-
CLINICAL_TRIALS study record update · 2012-09-12An Open Label, Randomized, Parallel Design Estimation Pilot Study to Compare the Effectiveness of 36 vs 48 Wks PegIntron Plus Ribavirin Treatment for HCV Patients Without Rapid Virologic Response(RVR) But With Undetectable HCV RNA at wk 8
-
CLINICAL_TRIALS study record update · 2011-09-27The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naive Genotype 1 Subjects With HIV Coinfection